Join
Live feed
·
INSIDERFilingvia Quantisnow
Entasis Therapeutics Holdings Inc. logo

SEC Form 4: Ronsheim Matthew was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 units

ByQuantisnow·Wall Street's wire, on your screen.
ETTX· Entasis Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ETTX (Entasis Therapeutics Holdings Inc.) and more on Quantisnow.

SEC Form 4: Ronsheim Matthew was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 units | Quantisnow